Close

Articles Posted in Good Manufacturing Process

Updated:

GlaxoSmithKline Settles Good Manufacturing Process Violations for $750 for Contaminated and Defective Pills

The DOJ reported today that SB Pharmco Puerto Rico Inc., a subsidiary of GlaxoSmithKline, pleaded guilty to False Claims Act charges and agreed to a fine totaling $750 million. The total includes a criminal fine of $150 million and a civil False Claims Act fine of $600 million. This case…

Contact Us